Amphastar Pharmaceuticals, Inc. (AMPH) Gross profit 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual gross profit history from SEC filings — each fiscal year as reported.
$356.1MFY2025 · since FY2016: $104.2M → $356.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $356.1M | -4.8% |
| FY2024 | $373.9M | +6.5% |
| FY2023 | $351.1M | +41.1% |
| FY2022 | $248.9M | +24.6% |
| FY2021 | $199.7M | +39.3% |
| FY2020 | $143.3M | +8.7% |
| FY2019 | $131.9M | +23.3% |
| FY2018 | $107.0M | +18.2% |
| FY2017 | $90.5M | -13.1% |
| FY2016 | $104.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice